OvaScience

OvaScience

Employees:
120
Market Cap:
$50.21 million
Revenue:
$826.5 thousand
Net Income:
$-76.53 million
NASDAQ:
OVAS

OvaScience is a publicly traded biotechnology company, focused on female infertility. It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair. Wikipedia

OvaScience

OvaScience is a publicly traded biotechnology company, focused on female infertility. It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair. Wikipedia

Employees:
120
Market Cap:
$50.21 million
Revenue:
$826.5 thousand
Net Income:
$-76.53 million
NASDAQ:
OVAS
  • Dec 22 at 11:26 PM
    Happiest of holidays from all of us at OvaScience.
  • Sep 18 at 7:33 PM
    All of us OvaScience had a great time at Resolve New England's #WalkofHope. Thank you to all of our employees, family and friends - and even pets who walked!
  • Sep 18 at 5:01 PM
    Thank you to our own Hannah Cummings Ph.D., who presented Evaluation of 4977 bp common deletion in human EggPC cell-derived mitochondria at the 63rd Annual Meeting of the Canadian Fertility and Andrology Society.
  • Jul 17 at 5:21 PM

Dec 22, 11:26 PM

Happiest of holidays from all of us at OvaScience.

Sep 18, 7:33 PM

All of us OvaScience had a great time at Resolve New England's #WalkofHope. Thank you to all of our employees, family and friends - and even pets who walked!

Sep 18, 5:01 PM

Thank you to our own Hannah Cummings Ph.D., who presented Evaluation of 4977 bp common deletion in human EggPC cell-derived mitochondria at the 63rd Annual Meeting of the Canadian Fertility and Andrology Society.

Jul 17, 5:21 PM